1-20 of 28
Sort by
News

Clonal Hematopoiesis May Prolong Cytopenias After CAR-T Therapy for MM

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Clonal Hematopoiesis May Prolong Cytopenias After CAR-T Therapy for MM
News

CAR-T Shows Acceptable Efficacy, Safety in Phase II R/R T-ALL/LBL Study

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, CAR-T Shows Acceptable Efficacy, Safety in Phase II R/R T-ALL/LBL Study
News

Physical Function Can Help Gauge ICANS Risk, Study Finds

Thomas R. Collins
Published: 2025
Abstract
February 2025
View News titled, Physical Function Can Help Gauge ICANS Risk, Study Finds
News

Multimodal, Machine Learning Boosts CAR-T Outcome Prediction in LBCL

Thomas R. Collins
Published: 2025
Abstract
February 2025
View News titled, Multimodal, Machine Learning Boosts CAR-T Outcome Prediction in LBCL
News

Cilta-Cel Achieves Rapid, Sustained MRD Negativity in Lenalidomide-Refractory MM as Early as First Relapse

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Cilta-Cel Achieves Rapid, Sustained MRD Negativity in Lenalidomide-Refractory MM as Early as First Relapse
News

Study Illuminates Clinical Characteristics, Molecular Origin of Post-CAR-T Treatment–Related Myeloid Neoplasms

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Study Illuminates Clinical Characteristics, Molecular Origin of Post-CAR-T Treatment–Related Myeloid Neoplasms
News

IL-15 Agonist Boosts Response in Phase II LBCL CAR-T Trial

Thomas R. Collins
Published: 2025
Abstract
February 2025
View News titled, IL-15 Agonist Boosts Response in Phase II LBCL CAR-T Trial
News

Predicting Response to Obe-Cel in Patients With R/R B-ALL

Lara C. Pullen, PhD
Published: 2025
Abstract
February 2025
View News titled, Predicting Response to Obe-Cel in Patients With R/R B-ALL
News

Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Relapse-Free Survival Progressively Shortens in Black Patients With Rituximab-Treated iTTP
News

February 2025 Data Stream

Published: 2025
Abstract
February 2025
View News titled, February 2025 Data Stream
News

Danicopan Plus Ravulizumab, Eculizumab Shows Long-Term Efficacy in PNH With Clinically Significant EVH

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Danicopan Plus Ravulizumab, Eculizumab Shows Long-Term Efficacy in PNH With Clinically Significant EVH
News

Combination of Venetoclax, Lower Intensity CPX-351 Shows Positive Results in Early-Stage AML Study

Anna Azvolinsky, PhD
Published: 2025
Abstract
February 2025
View News titled, Combination of Venetoclax, Lower Intensity CPX-351 Shows Positive Results in Early-Stage AML Study
News

Bevacizumab in Hereditary Hemorrhagic Telangiectasia (TRUST-HHT; NCT04404881)

Lara C. Pullen, PhD
Published: 2025
Abstract
February 2025
View News titled, Bevacizumab in Hereditary Hemorrhagic Telangiectasia (TRUST-HHT; NCT04404881)
News

Gerofit Exercise Intervention for Older Adults with Sickle Cell Disease (SICKLE-FIT; NCT05714098)

Lara C. Pullen, PhD
Published: 2025
Abstract
February 2025
View News titled, Gerofit Exercise Intervention for Older Adults with Sickle Cell Disease (SICKLE-FIT; NCT05714098)
News

Would you treat this patient for myelodysplastic syndromes or paroxysmal nocturnal hemoglobinuria?

Published: 2025
Abstract
February 2025
View News titled, Would you treat this patient for myelodysplastic syndromes or paroxysmal nocturnal hemoglobinuria?
News

You Make the Call: Would you treat this patient for myelodysplastic syndromes or paroxysmal nocturnal hemoglobinuria?

Published: 2025
Abstract
February 2025
View News titled, You Make the Call: Would you treat this patient for myelodysplastic syndromes or paroxysmal nocturnal hemoglobinuria?
News

ASH Publishes Guide to Boosting Accessibility, Diversity in Clinical Trials

Anna Azvolinsky, PhD
Published: 2025
Abstract
February 2025
View News titled, ASH Publishes Guide to Boosting Accessibility, Diversity in Clinical Trials
News

CRP Levels May Help Stratify VTE Risk in Patients With Cancer on ICIs

Ruth Jessen Hickman, MD
Published: 2025
Abstract
February 2025
View News titled, CRP Levels May Help Stratify VTE Risk in Patients With Cancer on ICIs
News

Therapy-Related Acute Leukemia Following AHCT for MM Remains Uncommon, Outcomes Remain Poor in Retrospective Analysis

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, Therapy-Related Acute Leukemia Following AHCT for MM Remains Uncommon, Outcomes Remain Poor in Retrospective Analysis
News

MRD Status Important Prognostic Factor for R/R MM Treated With T-Cell Redirecting Therapies

Leah Lawrence
Published: 2025
Abstract
February 2025
View News titled, MRD Status Important Prognostic Factor for R/R MM Treated With T-Cell Redirecting Therapies